Metastatic renal cell carcinoma, the possibility of targeted therapy. Case.
Malignant neoplasms of the kidney are quite an urgent problem. In the Russian Federation in 2019, 20758 patients with a newly diagnosed renal cell carcinoma were registered; it should be noted that at the end of 2019, 177 755 patients with this diagnosis were registered. Clear cell carcinoma of the...
Main Authors: | K. V. Menshikov, A. A. Izmailov, A. V. Sultanbaev, Sh. I. Musin, V. S. Chalov, I. A. Menshikova, N. I. Sultanbaeva, D. O. Lipatov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Remedium Group LLC
2021-12-01
|
Series: | Медицинский совет |
Subjects: | |
Online Access: | https://www.med-sovet.pro/jour/article/view/6591 |
Similar Items
-
Efficacy of the 1<sup>st</sup> generation tyrosine kinase inhibitor sunitinib in the treatment of metastatic renal cell carcinoma in alternative dosing regimens
by: K. V. Menshikov, et al.
Published: (2022-06-01) -
Does sunitinib still have a place in the current recommendations for the systemic treatment of advanced renal cell carcinoma?
by: M. I. Volkova, et al.
Published: (2021-08-01) -
An In Vitro Analysis of TKI-Based Sequence Therapy in Renal Cell Carcinoma Cell Lines
by: Angela Zaccagnino, et al.
Published: (2023-03-01) -
Böbrek Hücreli Karsinomlu Hastaların Demografik Özellikleri ve Tedavi Sonuçları: Tek Merkez Deneyimi
by: Arife Ulaş, et al.
Published: (2016-05-01) -
Connexin43 is associated with the progression of clear cell renal carcinoma and is regulated by tangeretin to sygergize with tyrosine kinase inhibitors
by: Yongchang Lai, et al.
Published: (2023-09-01)